1. Medtech Insight
  2. >>Device Area
  3. >>Diagnostics

LabCorp Launches COVID-19 Testing, Quest Diagnostics Will Provide Testing Starting 9 March In US

 
• By Marion Webb

LabCorp and Quest announced they will offer testing to detect COVID-19 to address the public health crisis.

Coronavirus blood sample

Laboratory Corp. of America Holdings announced on 5 March it will immediately offer testing for rapid detection of coronavirus COVID-19, which followed Quest Diagnostics Inc.'s same day announcement that it will be offering a testing service starting Monday, 9 March in the US.

The announcements follow a widespread effort by numerous diagnostic makers to introduce screening services in the US and elsewhere. Also...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diagnostics

Morphic Medical Prepares RESET Rollout In UK And Germany, Eyes Global Expansion In 5 Years

 
• By Shubham Singh

The company is undergoing major leadership changes, having appointed 30-year medtech veteran Jane Wright as chief financial officer on Sept. 12. Wright’s appointment follows Gutteridge’s own transition to CEO earlier this year.

Neurescue Wins CE Mark To Tackle 81% Of Cardiac Arrests AED’s Can’t Shock

 
• By Marion Webb

After receiving the CE marking for its non-shockable cardiac arrest treatment device, the Dutch medtech is looking for partners to bring it to Centers of Excellence.

Supreme Court Ruling Highlights Kennedy’s Role In Preventive Services Coverage

 
• By Tim Casey

The US Supreme Court ruled the Affordable Care Act’s preventive care coverage mandate is constitutional, but HHS Secretary Robert F. Kennedy Jr. may have gained more power over what is classified as preventive care.

Arima Genomics’ CEO Sets Sight On Replacing Standard Testing With 3D Genomics Lymphoma Assay

 
• By Marion Webb

Arima Genomics launched its new Aventa Lymphoma test aimed at helping pathologists detect lymphomas missed by standard FISH analysis. Initially positioned as complementary technology, Arima hopes to become the new standard test.

More from Device Area

FDA Oversight Still Falling Short on Women’s Safety, Advocate Finds

 
• By Elizabeth Orr

Device safety advocate Michelle Llamas says the FDA’s device review system leaves women at risk, citing weak oversight of 510(k) clearances, delayed safety warnings, and underrepresentation in trials. Her updated report urges stronger monitoring, transparency, and safeguards.

Pair Of Safety Alerts In Line With Broader FDA Enforcement Crackdown

 
• By Brian Bossetta

The US FDA issued two safety alerts concerning associated risks from unauthorized medical devices. The alerts are consistent with a larger effort to clamp down on consumer goods that have not been subject to agency review.

Mental Health The Focus Of Upcoming Digital Health Advisory Committee Meeting

 
• By Brian Bossetta

The US FDA will hold a public meeting of its Digital Health Advisory Committee in November to focus on generative AI-enabled medical devices to treat mental health.